top of page

Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina

Foto del escritor: Blueberries Medical CorpBlueberries Medical Corp

Toronto, Ontario (April 30, 2021) – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or “Blueberries”), is pleased to report its financial results for the year ended December 31, 2020. Blueberries has filed today its audited consolidated financial statements and related management’s discussion and analysis, both of which are available on Blueberries’ profile at www.sedar.com. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.




19 visualizaciones0 comentarios

Entradas recientes

Ver todo

Comments


bottom of page